Using a mix of remote, in-person and at-home care services, the program helps patients manage their CKD, slow down the progression to kidney failure and, if necessary, get prepared so that they’re not starting off dialysis in the hospital.
So-called conservative management can ease symptoms without dialysis in some people with kidney disease. But many of them are never given the option.
Hemodialysis is a life-sustaining treatment for kidney failure patients to clean and filter their blood of waste products, salts and excess fluid. However, this membrane-based therapy is not perfect, and hemodialysis patients experience acute side-effects, life-threatening chronic conditions and unacceptably high morbidity and mortality rates.
It would be far better for DaVita and Fresenius’s patients to get kidney transplants, which extends your lifespan by about 10 years on average, relative to remaining on dialysis, while avoiding exhausting, time-consuming treatment that makes holding down a job or traveling extremely difficult. But as Oliver notes, many dialysis centers fail to give patients information on transplantation, or actively discourage them from getting on the kidney waitlist. Partly as a result, about 40 percent of people eligible for a kidney transplant aren’t on the waiting list for one.
The development of dialysis by early pioneers such as Willem Kolff and Belding Scribner set in motion several dramatic changes in the epidemiology, economics and ethical frameworks for the treatment of kidney failure. However, despite a rapid expansion in the provision of dialysis — particularly haemodialysis and most notably in high-income countries (HICs) — the rate of true patient-centred innovation has slowed.
Kidney failure and its treatment dialysis is overwhelming the medical systems of many countries. Could home hemodialysis be the answer? Besides that, people may actually live longer and healthier lives!
Could an existing group of commonly used and relatively inexpensive prescription drugs save billions of dollars worldwide in healthcare costs. A doctor in Missouri seems to think so!
People over age 75 are the fastest-growing segment of patients on dialysis, and the treatment’s benefits and drawbacks add up differently for them than for younger patients. A growing number of nephrologists and researchers are pushing for more educated and deliberative decision making when seniors contemplate dialysis.
It is a choice, they say, not an imperative.
The number of patients requiring chronic hemodialysis is rapidly growing worldwide. Hemodialysis both greatly reduces quality of life and is associated with extremely high mortality rates. Management of care of patients requiring chronic hemodialysis is complex, and randomized controlled trials aimed at reducing primary outcomes of cardiovascular disease events, mortality, or both in this population have largely been unsuccessful.
EVERY WEEK, TWO million people across the world will sit for hours, hooked up to a whirring, blinking, blood-cleaning dialysis machine. Their alternatives: Find a kidney transplant or die.
It was not until the 1940s that researchers finally established a scientific basis advanced enough to support the first therapeutic trials. The discoveries and inventions of dedicated doctors and scientists are to thank for the advances that have cleared the way for continuous technological improvement over the decades.
It is starting to be recognised that some people with ESRD will not benefit from dialysis, particularly because it can shorten life. The difficulty is in identifying those for whom dialysis might hasten death. Increasing frailty, additional co-morbidities and poor functional status is likely to reduce your chance of effective dialysis.
Quality of life is another important issue.
Every year, more than 100,000 Americans start dialysis. One in four of them will die within 12 months—a fatality rate that is one of the worst in the industrialized world. Oh, and dialysis arguably costs more here than anywhere else.
I have had numerous people coming up to me in clubs, bars, shops, uni, you name it, questioning me about my arm.
Four kidneys, two transplants, one small girl, one big adventure
DPC is a non-profit patient organization dedicated to improving dialysis patients’ quality of life by developing awareness of dialysis issues, advocating for dialysis patients, promoting favorable public policy and improving the partnership between patients and caregivers.
A meeting place for people on dialysis to rant and vent their frustration about being on dialysis.
Originally published annually, since 2003 Hemodialysis International has published quarterly issues containing original papers on clinical and experimental topics related to dialysis, in addition to the Annual Dialysis Conference Proceedings. This journal is a must-have for nephrologists, nurses and technicians worldwide.
Hemodialysis, Inc. (Hi) is a health care management company which is committed to continually providing quality and excellence in the areas of education, training, and patient care.
The International Society for Hemodialysis (ISHD) was formed in 1999 by a group of world-renowned nephrologists who believed that the science and clinical practice of hemodialysis was being overlooked by the other major societies and journals in favor of molecular biology and other basic science-focused research endeavors. Their vision was to develop a society and journal focused primarily on the practice of clinical hemodialysis.
Seminars in Dialysis is a bimonthly publication focusing exclusively on cutting-edge clinical aspects of dialysis therapy. Besides publishing papers by the most respected names in the field of dialysis, the Journal has unique useful features, all designed to keep you current: dialysis clinic, dialysis rounds, hemodialysis citations, editorials, opinions, brief notes.
DOPPS investigations focus on determining which dialysis practices are associated with the best patient outcomes, with the primary goal of improving patient longevity, quality of life, and other outcomes. With over 75 peer-reviewed publications in print or in press, the DOPPS continues to provide numerous important findings that are relevant for patients and practicing clinicians alike.
The KIDNEY TRANSPLANT/DIALYSIS ASSOCIATION, INC. (KT/DA), is an all-volunteer, patient-run, non-profit organization made up of kidney dialysis and transplant patients, kidney donors, their families and friends, and health professionals.
Treatment Methods for Kidney Failure: Hemodialysis.